Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

International Journal of Molecular Sciences, 2025
Comparative Assessment of Acute Pulmonary Effects Induced by Heat-Not-Burn Tobacco Aerosol Inhalation in a Murine Model

Kim B., Yang W., Seong Y. et al.

Olink Target 96 MouseEnvironmental Health & ToxicologyPathophysiologyMouse Plasma

Frontiers in Immunology, 2025
Proteomics profiling of inflammatory responses to elexacaftor/tezacaftor/ivacaftor in cystic fibrosis

Ozuna H., Bojja D., Partida-Sanchez S. et al.

Olink Target 96Other Diseases & SyndromesPathophysiologyPlasma

Journal for ImmunoTherapy of Cancer, 2025
Transient lymphocyte count decrease correlates with oncolytic adenovirus efficacy in humans: mechanistic and biomarker findings from TUNIMO phase I trial

Pakola S., Clubb J., Kudling T. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPlasma

Scientific Reports, 2025
Interconnections between BDH1-plasma protein-type 2 diabetes Mellitus: a mediated mendelian randomization analysis using plasma proteomics

Liu Y., Zhang Y., Wan Q.

Olink Explore 3072/384Metabolic DiseasesPathophysiologyPlasma

The FASEB Journal, 2025
Novel inflammatory markers in intracerebral hemorrhage: Results from Olink proteomics analysis

Hu Z., Chen S., Zhang E. et al.

Olink Target 96CVDNeurologyPatient StratificationPlasma

Nature Genetics, 2025
Integrative proteogenomic analysis identifies COL6A3-derived endotrophin as a mediator of the effect of obesity on coronary artery disease

Yoshiji S., Lu T., Butler-Laporte G. et al.

Olink Explore 3072/384Metabolic DiseasesCVDCross-platform ValidationPlasma

CHEST Critical Care, 2025
Immunomodulation for acute respiratory distress syndrome: insights from proteomics in COVID-19

Rademaker E., Haitsma Mulier J., Drylewicz J. et al.

Olink Target 96Respiratory DiseasesInfectious DiseasesImmunotherapyPathophysiologyPlasma

Pediatric Research, 2025
Distinct pro-inflammatory/pro-angiogenetic signatures distinguish children with Long COVID from controls

Buonsenso D., Cotugno N., Amodio D. et al.

Olink Target 96Infectious DiseasesPediatricsPatient StratificationPlasma

British Journal of Dermatology, 2025
Orismilast, a phosphodiesterase 4B/D inhibitor, in moderate-to-severe atopic dermatitis: efficacy and safety from a multicentre randomized placebo-controlled phase IIb dose-ranging study (ADESOS)

Silverberg J., Eichenfield L., Blauvelt A. et al.

Olink Target 96Dermatological DiseasesPathophysiologyTape Strips

European Heart Journal, 2025
Fibroblast growth factor 5: a novel biomarker for familial hypercholesterolaemia

Baragetti A., Alieva A., Grigore L. et al.

Olink Target 96Metabolic DiseasesCVDPatient StratificationPlasma

European Heart Journal, 2025
Mosaic loss of Y chromosome and mortality after coronary angiography

Weyrich M., Zewinger S., Sarakpi T. et al.

Olink Target 96CVDPathophysiologyPlasma

Journal of Translational Medicine, 2025
Multi-omics analysis reveals novel causal pathways in psoriasis pathogenesis

Guo H., Gao J., Gong L. et al.

Olink Explore 3072/384Dermatological DiseasesPathophysiologyPlasma

European Journal of Preventive Cardiology, 2025
Fibroblast growth factor 23 and outcomes of atrial fibrillation: from clinical association to genetic evidence

Li J., Lai Y., Jiang C. et al.

Olink Explore 3072/384CVDPatient StratificationPlasma

Biomolecules, 2025
A Genetic and Environmental Analysis of Inflammatory Factors in Chronic Widespread Pain Using the TwinsUK Cohort

Cherny S., Livshits G., Williams F.

Olink Target 96NeurologyPathophysiologyPlasma

Hepatology International, 2025
Non-canonical Wnt signaling pathway activated NFATC3 promotes GDF15 expression in MASH: prospective analyses of UK biobank proteomic data

Wang H., Xu X., Shi L. et al.

Olink Explore 3072/384Metabolic DiseasesHepatologyPathophysiologyPlasma

European Journal of Heart Failure, 2025
Circulating growth differentiation factor‐15 levels are associated with early echocardiographic signs of diastolic function impairment in the STANISLAS cohort: A 20‐year follow‐up study

Monzo L., Xhaard C., Ferreira J. et al.

Olink Target 96CVDPatient StratificationPlasma

Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2025
Unraveling the impact of blood RANKL and OPG levels on Alzheimer's disease: Independent of bone mineral density and inflammation

Guo X., Shi W., Lu J. et al.

Olink Target 96NeurologyPathophysiologyPlasma

Clinical Proteomics, 2025
ARTN and CCL23 predicted chemosensitivity in acute myeloid leukemia: an Olink® proteomics approach

Wu T., Hsiao T., Chen C. et al.

Olink Explore 3072/384OncologyPatient StratificationBone Marrow Plasma

American Journal of Physiology-Heart and Circulatory Physiology, 2025
Chemerin is a new sex-specific target in aortic stenosis concomitant with diabetes regulated by the aldosterone/mineralocorticoid receptor axis

Goñi-Olóriz M., Garaikoetxea Zubillaga M., San Ildefonso-García S. et al.

Olink Target 96CVDMetabolic DiseasesPathophysiologyTissue Lysate

Cell, 2025
Systems-level immunomonitoring in children with solid tumors to enable precision medicine

Chen Q., Zhao B., Tan Z. et al.

Olink Target 96OncologyPediatricsPatient StratificationPlasma

4488 publications